Top compounds associated with response to BCL2


Feature Type Standardized
Nominal ANOVA
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.48 1e-25
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.32 6e-16
mRNA sotrastaurin CTRPv2 pan-cancer AAC 0.31 3e-13
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.39 9e-13
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.27 7e-12
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 8e-12
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 5e-11
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.23 1e-09
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 1e-09
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 6e-09
Download CSV